BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi Y, Chen W, Li C, Qi S, Zhou X, Zhang Y, Li Y, Li G. Clinicopathological characteristics and prediction of cancer-specific survival in large cell lung cancer: a population-based study. J Thorac Dis 2020;12:2261-9. [PMID: 32642131 DOI: 10.21037/jtd.2020.04.24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu T, Wei C, Zou X, Lu B, Wang Z. Case Report: Long-Term Survival With Anlotinib in a Patient With Advanced Undifferentiated Large-Cell Lung Cancer and Rare Tonsillar Metastasis. Front Oncol 2021;11:680818. [PMID: 34249723 DOI: 10.3389/fonc.2021.680818] [Reference Citation Analysis]
2 Wang W, Sun Y, Li H, Bao M, Liu X, Jiang G, Ye C, Hu Y. Surgical modality for stage IA non-small cell lung cancer among the elderly: analysis of the Surveillance, Epidemiology, and End Results database. J Thorac Dis 2020;12:6731-42. [PMID: 33282374 DOI: 10.21037/jtd-20-2221] [Reference Citation Analysis]
3 Wei T, Song J, Liang K, Li L, Mo X, Huang Z, Chen G, Mao N, Yang J. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. J Cancer Res Clin Oncol 2021;147:1049-64. [PMID: 33387038 DOI: 10.1007/s00432-020-03489-z] [Reference Citation Analysis]